We are live on ! Find out more
KXA

KPCB XV Associates Portfolio holdings

AUM $35.8M
1-Year Est. Return 57.59%
This Fund
S&P 500
This Quarter Est. Return
+13.13%
1 Year Est. Return
-57.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
-$8.11M
Cap. Flow
-$40.7M
Cap. Flow %
-18.19%
Top 10 Hldgs %
100%
Holding
4
New
Increased
1
Reduced
2
Closed

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$518K

Top Sells

Rank Stock Value
1
UPST icon
Upstart Holdings
UPST
+$26.1M
2
RAPT
RAPT Therapeutics
RAPT
+$15.2M

Sector Composition

Rank Sector Weight
1 Financials 35.45%
2 Technology 33.11%
3 Healthcare 31.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPST icon
1
Upstart Holdings
UPST
$2.8B
$79.4M 35.45%
635,841
-211,947
-25% -$26.1M
TWLO icon
2
Twilio
TWLO
$29.8B
$74.2M 33.11%
188,160
+1,493
+0.8% +$518K
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$41.2M 18.41%
162,133
-81,250
-33% -$15.2M
ATRA icon
4
Atara Biotherapeutics
ATRA
$77.8M
$29.2M 13.03%
75,066

Similar funds

KPCB XV Associates's Q2 2021 Portfolio in Review

As of Q2 2021, KPCB XV Associates held 4 positions worth $224M, down 3.5% from $232M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XV Associates withdrew a net $40.7M in Q2 2021, reducing 2 holdings. Its largest reduction was Upstart Holdings, cutting an estimated $26.1M.

By sector, the portfolio is most concentrated in Financials at 35% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.

Against the trend, KPCB XV Associates added an estimated $518K to Twilio.

  • KPCB XV Associates added most to Twilio in Q2 2021, an estimated $518K increase.
  • KPCB XV Associates's biggest Q2 2021 reduction was Upstart Holdings, cutting an estimated $26.1M.
  • KPCB XV Associates's ten largest holdings make up 100% of its $224M portfolio in Q2 2021.
  • KPCB XV Associates opened 0 new positions and closed 0 in Q2 2021.
  • KPCB XV Associates's portfolio value fell 3.5% quarter-over-quarter to $224M.

Based on KPCB XV Associates's 13F filing for Q2 2021, filed 28 Jul 2021.